<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-15T06:11:09Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.09242" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.09242</identifier>
    <datestamp>2024-05-31T11:30:59Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2024-05-31</dc:date>
  <dc:title>Fibroblast growth factor 21 exhibits neuroprotective effects by promoting 5-HT1AR-FGFR1 heteroreceptor complexes activation triggering MEK1/2-ERK1/2 signaling pathway</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.09242</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>&amp;nbsp;Approaches of promoting a neural milieu permissive for plasticity and resilience against neuronal injury are the important strategy for the treatment of a range of neurological disorders.&amp;nbsp;Fibroblast growth factor 21 (FGF21)&amp;nbsp;which is known for its role as a potent regulator of glucose and energy metabolism has also proved to be neuroprotective against various mental diseases. However, the underlying molecular mechanisms remain elusive. Here, we report a study in vivo&amp;nbsp;and in vitro&amp;nbsp;of the neuroprotective effects of FGF21&amp;nbsp;by triggering the signaling pathway of 5-HT1AR-FGFR1 heteroreceptor complexes in normal or abnormal neurological conditions.&amp;nbsp;</dc:description>
  <dc:subject>Neurological damage; FGFR1-5-HT1AR heteromer; Neuroprotection</dc:subject>
  <dc:creator>ShulingWang</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>